The latest news on life science tools and technology in genetics, genomics, and molecular diagnostics.
With EMR upgrades, Penn and Rush now have structured genomic data informing clinical decision support in their precision oncology programs, but much work remains.
The analysis also suggested ways to outwit these mechanisms based on the degree of immune cell infiltration into the tumor.
Genetron will provide clinical trial genomic testing and companion diagnostic development services for InnoCare's biomarker-driven oncology drug development.
The groups have written draft recommendations and are now asking for public comment from pathologists and other stakeholders.
The high-throughput S2000 sequencer is the second instrument Genetron Health has received NMPA approval for, following the S5 benchtop instrument last year.